Search images on Google      Product Monograph

Active Ingredients:

• caplacizumab, 11 MG/VIAL

DIN: 02496194

Dosage Form(s): KIT, POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: SANOFI-AVENTIS CANADA INC  –  official site

ATC:

• B01 - ANTITHROMBOTIC AGENTS (ATC, WHO, Wiki)
• B01A - ANTITHROMBOTIC AGENTS (ATC, WHO)
• B01AX - Other antithrombotic agents (ATC, WHO)
• B01AX07 - CAPLACIZUMAB (WHO)

 

External Links for Cablivi:

Search on Google

• Cablivi side effects
• Cablivi dosage
• caplacizumab side effects
• caplacizumab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find cablivi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.